- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Jun 12, 2026)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Jun 15, 2026 | A-232-25 | APP | The Lounge Medical Spa Ltd. Et Al V. Dermaspark Products Inc. Et Al (Trade-mark) | Edmonton | 0 |
| Jun 15, 2026 | A-278-25 | APP | Roula Hamdan Et Al. V. Dermaspark Products Inc. Et Al. (Trade-mark) | Edmonton | 0 |
| Jun 15, 2026 | T-713-20 | M | Ha Vi Doan V. Clearview Ai Inc. (Copyright) | Montréal | 1 d |
| Jun 16, 2026 | T-3381-25 | CMC | Maxunitech North America, Inc. Et Al. V. Sharda Cropchem Limited (Patent) | Toronto | 1 h |
| Jun 17, 2026 | T-7-25 | PTC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 1 d |
| Jun 17, 2026 | T-8-25 | PTC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 1 d |
| Jun 17, 2026 | T-9-25 | PTC | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 1 d |
| Jun 17, 2026 | T-2669-22 | PTC | Cangas Propane Inc. V. Canagas Incorporated (Trade Mark) | Ottawa | 3 h |
| Jun 17, 2026 | T-1085-15 | CMC | 1395804 Ontario Ltd., Operation As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Jun 17, 2026 | T-132-17 | CMC | 1395804 Ontario Ltd., Operaring As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Jun 17, 2026 | T-133-17 | CMC | 1395804 Ontario Ltd., Operating As Blacklock's Reporter V. Agc (unknown) | Ottawa | 1 h |
| Jun 17, 2026 | T-134-17 | CMC | 1395804 Ontario Ltd V. Financial Transactions And Reports Analysis Centre (unknown) | Ottawa | 1 h |
| Jun 17, 2026 | T-2042-16 | CMC | 1395804 Ontario Ltd., Operating As Blacklock's Reporter V. Agc (Copyright) | Ottawa | 1 h |
| Jun 17, 2026 | T-2090-14 | CMC | 1395804 Ontario Ltd V. Canada (ag) (Copyright) | Ottawa | 1 h |
| Jun 17, 2026 | T-943-17 | CMC | 1395804 Ontario Ltd. V. The Canadian Energy Regulator (Copyright) | Ottawa | 1 h |
| Jun 17, 2026 | T-2043-26 | CMC | Astellas Pharma Canada Inc. Et Al. V. Mint Pharmaceuticals Inc. (Patent - Mirabegron*) | Toronto | 1 h |
| Jun 18, 2026 | T-1596-24 | M | Great Bowery Inc. D/b/a "trunk Archive" Et Al V. Valnet Inc. (Copyright) | Toronto | 3 h |
| Jun 18, 2026 | T-2620-25 | M | Solucore Inc. Et Al. V. Kja Consultants Inc. Et Al. (Patent) | Toronto | 2 h |
| Jun 19, 2026 | T-1567-24 | TMC | Justin Stitches Inc. V. Makers Holdings Inc. (Trade Mark) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Aug 17, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 17, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 17, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 24, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 24, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 24, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 31, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 31, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 5 d |
| Aug 31, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 5 d |
| Sep 8, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 4 d |
| Sep 14, 2026 | T-1567-24 | Justin Stitches Inc. V. Makers Holdings Inc. (Trade Mark) | Vancouver | 5 d |
| Sep 16, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 2 d |
| Oct 19, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 10 d |
| Oct 19, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Oct 26, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Nov 4, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 2 d |
| Nov 9, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 12, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 18, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 2 d |
| Nov 23, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 8 d |
| Dec 7, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 2 d |
| Jan 18, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Jan 25, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Feb 3, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 2 d |
| Mar 10, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 10 d |
| Mar 10, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 10 d |
| Mar 30, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 2 d |
| Mar 30, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Apr 19, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| Apr 26, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| May 10, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 2 d |
| May 10, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 4 d |
| May 17, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 3 d |
| May 25, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 2 d |
| Jun 22, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 9 d |
| Jun 28, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 3 d |
| Jul 2, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 5 d |
| Jul 7, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 2 d |
| Jul 15, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Aug 9, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 10 d |
| Aug 26, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 2 d |
| Sep 7, 2027 | T-1742-23 | Dermaspark Products Inc. Et Al. V. Dynamite Beauty Academy Ltd Et Al. (Trade Mark) | Vancouver | 4 d |
| Sep 13, 2027 | T-1742-23 | Dermaspark Products Inc. Et Al. V. Dynamite Beauty Academy Ltd Et Al. (Trade Mark) | Vancouver | 2.3 d |
| Oct 19, 2027 | T-846-26 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Sacubitril*) | Ottawa | 8 d |
| Nov 8, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 10 d |
| Nov 22, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 4 d |
| Nov 22, 2027 | T-1545-26 | Taiho Pharmaceutical Co., Ltd Et Al. V. Natco Pharma (canada) Inc. (Patent - Trifluridine*) | Toronto | 4 d |
| Nov 24, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
| Nov 29, 2027 | T-1545-26 | Taiho Pharmaceutical Co., Ltd Et Al. V. Natco Pharma (canada) Inc. (Patent - Trifluridine*) | Toronto | 4 d |
| Nov 29, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 4 d |
| Dec 6, 2027 | T-1545-26 | Taiho Pharmaceutical Co., Ltd Et Al. V. Natco Pharma (canada) Inc. (Patent - Trifluridine*) | Toronto | 5 d |
| Dec 7, 2027 | T-1266-26 | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 2 d |
| Dec 16, 2027 | T-1545-26 | Taiho Pharmaceutical Co., Ltd Et Al. V. Natco Pharma (canada) Inc. (Patent - Trifluridine*) | Ottawa | 2 d |
| Jan 10, 2028 | T-2038-26 | Vertex Pharmaceuticals (canada) Inc. Et Al. V. Jamp Pharma Corp. (Patent - Ivacaftor*) | Toronto | 9 d |
| Jan 26, 2028 | T-2038-26 | Vertex Pharmaceuticals (canada) Inc. Et Al. V. Jamp Pharma Corp. (Patent - Ivacaftor*) | Toronto | 1 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Jun 22, 2026 | T-1127-26 | Rogers Media Inc. Et Al. V. John Doe 1 Dba Apollo Group Tv Et Al. | Copyright Infringement [Applications] | Toronto | 3 h |
| Jul 2, 2026 | T-1879-25 | Rex International Food Inc. V. 9107-7438 Quebec Lnc. D.b.a Akhavan Food | S. 18.1 Application for Judicial Review | Ottawa | 2 h |
| Jul 20, 2026 | T-2315-24 | Obsidian Group Inc. V. Les Chocolats Vadeboncoeur Inc. | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 3 h |
| Aug 17, 2026 | T-3013-24 | Faisal Anashara V. Bizu Innovation Group | Trade Mark Expungement | Toronto | 1 h |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Jun 15, 2026 | A-232-25 | The Lounge Medical Spa Ltd. Et Al V. Dermaspark Products Inc. Et Al | Appeal (S.27 - Final) - Trade-marks Act | Edmonton |
| Jun 15, 2026 | A-278-25 | Roula Hamdan Et Al. V. Dermaspark Products Inc. Et Al. | Appeal (S.27 - Final) - Trade-marks Act | Edmonton |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.